The china pharmaceutical contract manufacturing market is anticipated to grow at a considerable CAGR of around 12.1% during the forecast period (2021-2027). The increasing demand for API manufacturing has witnessed constant growth over the given forecast period. Also, it is projected to continue increasing with further patent expirations estimated in the future, and a resulting rise in […]